Review Article

Comparison of 1L Adjuvant Auxiliary Preparations with 2L Solely Polyethylene Glycol plus Ascorbic Acid Regime for Bowel Cleaning: A Meta-analysis of Randomized, Controlled Trials

Table 1

Baseline characteristics of included randomized controlled trials.

Study, year (country)Source of patientsExperimental groups1L, 2L, Use of adjuvantTime of first and last doseProcedure timeDietOutcomesType of study

Kwon et al. [18], 2016 (Korea)OutpatientFD: Bis+0.5 L water
LD: water
919620 mg bisacodylFD: 8 pm day-prior
LD: 6 am day-of
≥3 h interval before3-day low residualBBPSMulticenter, single-blind, RCT
Kang et al. [19], 2017 (Korea)OutpatientFD: Bis
LD:
10010010 mg bisacodylFD: 9 pm day-prior
LD: ≥4 h prior
9 am-13 pm3-day low residualBBPS, ABPSSingle-center, single-blind, RCT
Choi et al. [17], 2019 (Korea)OutpatientFD:
LD:
1301302 mg prucaloprideFD: 7 pm day-prior
LD: ≥5 h prior
9 am-13 pm3-day low residualBBPS, ABPSSingle-center, single-blind, RCT
Kim et al. [20], 2019 (Korea)OutpatientFD: —
LD:
838520 mg bisacodyl (suppository)FD: —
LD: 5 am day-of
8 : 30 am-12 pm1-day clear liquidBBPSSingle-center, single-blind, RCT
Kim et al. [21], 2020 (Korea)NAFD: Bis
LD:
999910 mg bisacodylFD: 9 pm day-prior
LD: ≥5 h prior
9 am-17 pm3-day low residualBBPSSingle-center, single-blind, RCT

ABPS: Aronchick Bowel Preparation Scale; BBPS: Boston Bowel Preparation Scale; Bis: bisacodyl; FD: first dose; LD: last dose; PEG-Asc: polyethylene glycol plus ascorbic acid; Pru: prucalopride; RCT: randomized controlled trial; 1 L: 1 L polyethylene glycol plus ascorbic acid with adjuvant drug; 2 L: 2 L polyethylene glycol plus ascorbic acid.